Buxton helmsley releases evidence of product-related fraud at assertio

New york--(business wire)--the buxton helmsley group, inc. (together with certain of its affiliates, “bhg” or “we”), a new york city-based investment fund manager that has inverted its long equity position into that of a short interest in the publicly traded securities of assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), today responded to the company's attempt to deny, in its november 11, 2024, press release, the evident product-related fraud at spectrum pharmaceuticals, in.
ASRT Ratings Summary
ASRT Quant Ranking